PLGA nanofibers improves the antitumoral effect of daunorubicin

Colloids and Surfaces B: Biointerfaces

Volumn 136, Issue , 2015, Pages 248-255

  Guimarães, Pedro P G ^a   Oliveira, Michele F ^a   Gomes, Alinne D M ^a   Gontijo, Sávio M L ^a   Cortés, Maria E ^a   Campos, Paula P ^a   Viana, Celso T R ^a   Andrade, Silvia P ^a   Sinisterra, Rubén D ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Daunorubicin; Drug delivery system; Electrospinning; PLGA nanofibers

Indexed keywords

CELL CULTURE; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DIFFERENTIAL THERMAL ANALYSIS; ELECTROSPINNING; FLUORESCENCE MICROSCOPY; SCANNING ELECTRON MICROSCOPY; SPINNING (FIBERS); THERMOANALYSIS; THERMOGRAVIMETRIC ANALYSIS; X RAY DIFFRACTION;

ANTI-INFLAMMATORIES; CONFOCAL FLUORESCENCE MICROSCOPY; DAUNORUBICIN; DIFFERENTIAL THERMAL ANALYSES (DTA); DRUG DELIVERY SYSTEM; ELECTROSPINNING PROCESS; POLY LACTIC-CO-GLYCOLIC ACID; ZERO ORDER KINETICS;

NANOFIBERS;

DAUNORUBICIN; HEMOGLOBIN; MYELOPEROXIDASE; N ACETYL BETA GLUCOSAMINIDASE; NANOFIBER; POLYGLACTIN; VASCULOTROPIN; ANTINEOPLASTIC ANTIBIOTIC; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG RELEASE; ELECTROSPINNING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERMOGRAVIMETRY; ANIMAL; CELL LINE; CHEMISTRY; FLUORESCENCE MICROSCOPY; SCANNING ELECTRON MICROSCOPY; TUMOR CELL LINE; X RAY DIFFRACTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE; CELL LINE, TUMOR; DAUNORUBICIN; HUMANS; LACTIC ACID; MALE; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; NANOFIBERS; POLYGLYCOLIC ACID; X-RAY DIFFRACTION;

EID: 84942240109     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.09.005     Document Type: Article

References (62)

1. Gu F.X., Karnik R., Wang A.Z., Alexis F., Levy-Nissenbaum E., Hong S., Langer R.S., Farokhzad O.C. Targeted nanoparticles for cancer therapy. Nano Today 2007, 2:14-21.
2. Markman J.L., Rekechenetskiy A., Holler E., Ljubimova J.Y. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv. Drug Deliv. Rev. 2013, 65:1866-1879.
3. Ma P., Mumper R.J. Anthracycline nano-delivery systems to overcome multiple drug resistance: a comprehensive review. Nano Today 2013, 8:313-331.
4. Batrakova E.V., Dorodnych T.Y., Klinskii E.Y., Kliushnenkova E.N., Shemchukova O.B., Goncharova O.N., Arjakov S.A., Alakhov V.Y., Kabanov A.V. Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. Br. J. Cancer 1996, 74:1545-1552.
5. Drbohlavova J., Chomoucka J., Adam V., Ryvolova M., Eckschlager T., Hubalek J., Kizek R. Nanocarriers for anticancer drugs-new trends in nanomedicine. Curr. Drug Metab. 2013, 14:547-564.
6. Li L., Hsieh Y.L. Ultra-fine polyelectrolyte fibers from electrospinning of poly(acrylic acid). Polymer 2005, 46:5133-5139.
7. Wang H.G., Liu Q.W., Yang Q.B., Li Y.C., Wang W., Sun L., Zhang C.Q., Li Y.X. Electrospun poly(methyl methacrylate) nanofibers and microparticles. J. Mater. Sci. 2010, 45:1032-1038.
8. Greiner A., Wendorff J.H. Electrospinning: a fascinating method for the preparation of ultrathin fibres. Angew. Chem. Int. Ed. 2007, 46:5670-5703.
9. Liang D., Hsiao B.S., Chu B. Functional electrospun nanofibrous scaffolds for biomedical applications. Adv. Drug Deliv. Rev. 2007, 59:1392-1412.
10. Sill T.J., von Recum H.A. Electro spinning: applications in drug delivery and tissue engineering. Biomaterials 2008, 29:1989-2006.
11. Meinel A.J., Germershaus O., Luhmann T., Merkle H.P., Meinel L. Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur. J. Pharm. Biopharm. 2012, 81:1-13.
12. Xie C.Y., Li X.H., Luo X.M., Yang Y., Cui W.G., Zou J., Zhou S.B. Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations. Int. J. Pharm. 2010, 391:55-64.
13. Hua X., Liu S., Zhou G., Huang Y., Xie Z., Jinga X. Electrospinning of polymeric nanofibers for drug delivery applications. J. Controlled Release 2014, 185:12-21.
14. Li J.Y., Chen C., Wang X.M., Gu Z.Z., Chen B.A. Novel strategy to fabricate PLA/Au nanocomposites as an efficient drug carrier for human leukemia cells in vitro. Nanoscale Res. Lett. 2011, 6:8.
15. Song M., Pan C., Chen C., Li J.Y., Wang X.M., Gu Z.Z. The application of new nanocomposites: enhancement effect of polylactide nanofibers/nano-TiO(2) blends on biorecognition of anticancer drug daunorubicin. Appl. Surf. Sci. 2008, 255:610-612.
16. 4 and polylactide nanofibers for application in drug uptake and induction of cell death of leukemia cancer cells. Langmuir 2008, 24:2151-2156.
17. Gong Z.L., Tang D.Y., Zhang X.D., Ma J., Mao Y. Self-assembly of thermoresponsive nanocomposites and their applications for sensing daunorubicin with DNA. Appl. Surf. Sci. 2014, 316:194-201.
18. Song M., Pan C., Chen C., Li J., Wang X., Gu Z. The application of new nanocomposites: enhancement effect of polylactide nanofibers/nano-TiO(2) blends on biorecognition of anticancer drug daunorubicin. Appl. Surf. Sci. 2008, 255:610-612.
19. 2 and PLA polymer on the interaction of antitumor drug with DNA. Electroanalysis 2006, 18:1995-2000.
20. 2 nanoparticles and poly (N-isopropylacrylamide)-co-poly styrene nanofibers as a means to promote the biorecognition of an anticancer drug. Talanta 2008, 75:1035-1040.
21. Song M., Guo D., Pan C., Jiang H., Chen C., Zhang R., Gu Z., Wang X. The application of poly(N-isopropylacrylamide)-co-polystyrene nanofibers as an additive agent to facilitate the cellular uptake of an anticancer drug. Nanotechnology 2008, 19.
22. Chen C., Lv G., Pan C., Song M., Wu C., Guo D., Wang X., Chen B., Gu Z. Poly(lactic acid) (PLA) based nanocomposites-a novel way of drug-releasing. Biomed. Mater. 2007, 2:L1-L4.
23. Li J., Chen C., Wang X., Gu Z., Chen B. Novel strategy to fabricate PLA/Au nanocomposites as an efficient drug carrier for human leukemia cells in vitro. Nanoscale Res. Lett. 2011, 6.
24. 4 and polylactide nanofibers for application in drug uptake and induction of cell death of leukemia cancer cells. Langmuir 2008, 24:2151-2156.
25. Guimarães P.P., Oliveira S.R., de C., Astro R., Odrigues G., Gontijo S.M., Lula I.S., Cortés M.E., Denadai Â.M., SRD Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability. Molecules 2015, 20:879-899.
26. Andrade S., Fan T.P., Lewis G. Quantitative in-vivo studies on angiogenesis in a rat sponge model. Br. J. Exp. Pathol. 1987, 68:755-766.
27. Mendes J.B., Rocha M.A., Araujo F.A., Moura S.A.L., Ferreira M.A.N.D., Andrade S.P. Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice. Microvasc. Res. 2009, 78:265-271.
28. Marques S.M., Campos P.P., Castro P.R., Cardoso C.C., Ferreira M.A.N.D., Andrade S.P. Genetic background determines mouse strain differences in inflammatory angiogenesis. Microvasc. Res. 2011, 82:246-252.
29. Teixeira A.S., Araujo F.A., Ferreira M., Barcelos L.S., Teixeira M.M., Andrade S.P. Angiogenesis and inflammation in skeletal muscle in response to ascites tumor in mice. Life Sci. 2006, 78:1637-1645.
30. Castro P.R., Marques S.M., Campos P.P., Cardoso C.C., Sampaio F.P., Ferreira M.A.N.D., Andrade S.P. Kinetics of implant-induced inflammatory angiogenesis in abdominal muscle wall in mice. Microvasc. Res. 2012, 84:9-15.
31. Zamani M., Morshed M., Varshosaz J., Jannesari M. Controlled release of metronidazole benzoate from poly epsilon-caprolactone electrospun nanofibers for periodontal diseases. Eur. J. Pharm. Biopharm. 2010, 75:179-185.
32. Fouad H., Elsarnagawy T., Almajhdi F.N., Khalil K.A. Preparation and in vitro thermo-mechanical characterization of electrospun PLGA nanofibers for soft and hard tissue replacement. Int. J. Electrochem. Sci. 2013, 8:2293-2304.
33. Qu Z.J., Kang X.J., Wu W.W., Chen B.A., Gu Z.Z. Preparation of novel packed-nanofibers solid phase extraction column and its application to the determination of daunorubicin in rat tissues. Chin. J. Anal. Chem. 2011, 39:312-316.
34. Song M., Wang X.M., Wang C.X., Pan C., Fu D.G., Gu Z.Z. Application of the blending of PNIPAM-co-PS nanofibers with functionalized au nanoparticles for the high-sensitive diagnosis of cancer cells. J. Nanosci. Nanotechnol. 2009, 9:876-879.
35. 2 nanoparticles and poly (N-isopropylacrylamide)-co-poly styrene nanofibers as a means to promote the biorecognition of an anticancer drug. Talanta 2008, 75:1035-1040.
36. Song M., Guo D.D., Pan C., Jiang H., Chen C., Zhang R.Y., Gu Z.Z., Wang X.M. The application of poly(N-isopropylacrylamide)-co-polystyrene nanofibers as an additive agent to facilitate the cellular uptake of an anticancer drug. Nanotechnology 2008, 19:7.
37. Chen C., Lv G., Pan C., Song M., Wu C.H., Guo D.D., Wang X.M., Chen B.A., Gu Z.Z. Poly(lactic acid) (PLA) based nanocomposites-a novel way of drug-releasing. Biomed. Mater. 2007, 2:L1-L4.
38. 2 and PLA polymer on the interaction of antitumor drug with DNA. Electroanalysis 2006, 18:1995-2000.
39. Hu X.L., Liu S., Zhou G.Y., Huang Y.B., Xie Z.G., Jing X.B. Electrospinning of polymeric nanofibers for drug delivery applications. J. Controlled Release 2014, 185:12-21.
40. Sohrabi A., Shaibani P.M., Etayash H., Kaur K., Thundat T. Sustained drug release and antibacterial activity of ampicillin incorporated poly(methyl methacrylate)-nylon6 core/shell nanofibers. Polymer 2013, 54:2699-2705.
41. Jannesari M., Varshosaz J., Morshed M., Zamani M. Composite poly(vinyl alcohol)/poly(vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs. Int. J. Nanomed. 2011, 6:11.
42. Gagandeep T., Garg B., Malik G., Rath A.K.G., Oyal Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur. J. Pharm. Sci. 2014, 53:10-16.
43. Chen D.W., Hsu Y.H., Liao J.Y., Liu S.J., Chen J.K., Ueng S.W.N. Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes. Int. J. Pharm. 2012, 430:335-341.
44. Zahedi P., Karami Z., Rezaeian I., Jafari S.H., Mahdaviani P., Abdolghaffari A.H., Abdollahi M. Preparation and performance evaluation of tetracycline hydrochloride loaded wound dressing mats based on electrospun nanofibrous poly(lactic acid)/poly(ε-caprolactone) blends. J. Appl. Polym. Sci. 2012, 124:4174-4183.
45. Kim K., Luu Y.K., Chang C., Fang D.F., Hsiao B.S., Chu B., Hadjiargyrou M. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J. Controlled Release 2004, 98:47-56.
46. Metaxa A.F., Efthimiadou E.K., Boukos N., Fragogeorgi E.A., Loudos G., Kordas G. Hollow microspheres based on-folic acid modified-hydroxypropyl cellulose and synthetic multi-responsive bio-copolymer for targeted cancer therapy: controlled release of daunorubicin, in vitro and in vivo studies. J. Colloid Interface Sci. 2014, 435:171-181.
47. Lu T.C., Jing X.B., Song X.F., Wang X.R. Doxorubicin-loaded ultrafine PEG-PLA fiber mats against hepatocarcinoma. J. Appl. Polym. Sci. 2012, 123:209-217.
48. Nitanan T., Akkaramongkolporn P., Ngawhirunpat T., Rojanarata T., Panomsuk S., Opanasopit P. Fabrication and evaluation of cationic exchange nanofibers for controlled drug delivery systems. Int. J. Pharm. 2013, 450:345-353.
49. Luong-Van E., Grondahl L., Chua K.N., Leong K.W., Nurcombe V., Cool S.M. Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials 2006, 27:2042-2050.
50. Fredenberg S., Wahlgren M., Reslow M., Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems-a review. Int. J. Pharm. 2011, 415:34-52.
51. Ma G.P., Liu Y., Peng C., Fang D.W., He B.J., Nie J. Paclitaxel loaded electrospun porous nanofibers as mat potential application for chemotherapy against prostate cancer. Carbohydr. Polym. 2011, 86:505-512.
52. Mahoney B.P., Raghunand N., Baggett B., Gillies R.J. Tumor acidity, ion trapping and chemotherapeutics I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem. Pharmacol. 2003, 66:1207-1218.
53. Campos P.P., Bakhle Y.S., Andrade S.P. Mechanisms of wound healing responses in lupus-prone New Zealand White mouse strain. Wound Repair Regener. 2008, 16:416-424.
54. Ferreira M., Barcelos L.S., Campos P.P., Vasconcelos A.C., Teixeira M.M., Andrade S.P. Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO). Br. J. Pharmacol. 2004, 141:1185-1192.
55. Chan J.M., Zhang L.F., Yuet K.P., Liao G., Rhee J.W., Langer R., Farokhzad O.C. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009, 30:1627-1634.
56. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008, 7.
57. Hu D.E., Hiley C.R., Smither R.L., Gresham G.A., Fan T.P.D. Correlation of Xe-133 clearance, blood-flow and histology in the rat sponge model for angiogenesis-further-studies with angiogenic modifiers. Lab. Invest. 1995, 72:601-610.
58. Wohlfart S., Khalansky A.S., Gelperina S., Maksimenko O., Bernreuther C., Glatzel M., Kreuter J. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One 2011, 6:8.
59. Makadia H.K., Siegel S.J. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 2011, 3:1377-1397.
60. Iwase T., Fu J., Yoshida T., Muramatsu D., Miki A., Hashida N., Lu L.L., Oveson B., Silva R.L.E., Seidel C., Yang M., Connelly S., Shen J.K., Han B., Wu M.S., Semenza G.L., Hanes J., Campochiaro P.A. Sustained delivery of a HIF-1 antagonist for ocular neovascularization. J. Controlled Release 2013, 172:625-633.
61. Lee K., Qian D.Z., Rey S., Wei H., Liu J.O., Semenza G.L. Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2353-2358.
62. Sung H.J., Meredith C., Johnson C., Galis Z.S. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004, 25:5735-5742.